Resveratrol Induces Vascular Smooth Muscle Cell Differentiation through Stimulation of SirT1 and AMPK

被引:79
作者
Thompson, Anne Marie [1 ]
Martin, Kathleen A. [2 ]
Rzucidlo, Eva M. [1 ]
机构
[1] Dartmouth Med Sch, Vasc Surg Sect, Lebanon, NH USA
[2] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06504 USA
关键词
SIRTUINS; DISEASE; NAD(+);
D O I
10.1371/journal.pone.0085495
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Phenotypic plasticity in vascular smooth muscle cells (VSMC) is necessary for vessel maintenance, repair and adaptation to vascular changes associated with aging. De-differentiated VSMC contribute to pathologies including atherosclerosis and intimal hyperplasia. As resveratrol has been reported to have cardio-protective effects, we investigated its role in VSMC phenotypic modulation. We demonstrated the novel finding that resveratrol promoted VSMC differentiation as measured by contractile protein expression, contractile morphology and contraction in collagen gels. Resveratrol induced VSMC differentiation through stimulation of SirT1 and AMPK. We made the novel finding that low or high dose resveratrol had an initially different mechanism on induction of differentiation. We found that low dose resveratrol stimulated differentiation through SirT1-mediated activation of AKT, whereas high dose resveratrol stimulated differentiation through AMPK-mediated inhibition of the mTORC1 pathway, allowing activation of AKT. The health effects of resveratrol in cardiovascular diseases, cancer and longevity are an area of active research. We have demonstrated a supplemental avenue where-by resveratrol may promote health by maintaining and enhancing plasticity of the vasculature.
引用
收藏
页数:10
相关论文
共 23 条
[1]  
Baur J, 2006, NATURE REV, V5
[2]   Are sirtuins viable targets for improving healthspan and lifespan? [J].
Baur, Joseph A. ;
Ungvari, Zoltan ;
Minor, Robin K. ;
Le Couteur, David G. ;
de Cabo, Rafael .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (06) :443-461
[3]   NAD+, Sirtuins, and Cardiovascular Disease [J].
Borradaile, Nica M. ;
Pickering, J. Geoffrey .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (01) :110-117
[4]   AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity [J].
Canto, Carles ;
Gerhart-Hines, Zachary ;
Feige, Jerome N. ;
Lagouge, Marie ;
Noriega, Lilia ;
Milne, Jill C. ;
Elliott, Peter J. ;
Puigserver, Pere ;
Auwerx, Johan .
NATURE, 2009, 458 (7241) :1056-U140
[5]   Resveratrol: French paradox revisited [J].
Catalgol, Betul ;
Batirel, Saime ;
Taga, Yavuz ;
Ozer, Nesrin Kartal .
FRONTIERS IN PHARMACOLOGY, 2012, 3
[6]  
Chang Z., 2010, frontiers in bioscience
[7]  
Ding M, 2011, ARTERIOSCLEROSIS THR, V31
[8]   SIRT1 Takes a Backseat to AMPK in the Regulation of Insulin Sensitivity by Resveratrol [J].
Fullerton, Morgan D. ;
Steinberg, Gregory R. .
DIABETES, 2010, 59 (03) :551-553
[9]   SIRT1 Negatively Regulates the Mammalian Target of Rapamycin [J].
Ghosh, Hiyaa Singhee ;
McBurney, Michael ;
Robbins, Paul D. .
PLOS ONE, 2010, 5 (02)
[10]   Mammalian Sirtuins: Biological Insights and Disease Relevance [J].
Haigis, Marcia C. ;
Sinclair, David A. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2010, 5 :253-295